Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials

Harris A Ahmad, James E East, Remo Panaccione, Simon Travis, James B Canavan, Keith Usiskin, Michael F Byrne

In this review, state-of-the-art endoscopic assessment of mucosal disease activity in inflammatory bowel disease clinical trials is described, covering the potential for artificial intelligence to transform the current paradigm, its limitations, and suggested next steps.

“Artificial Intelligence solutions will change how clinical trials are conducted….for the better! Our review in Journal of Crohn’s and Colitis, jjad029 describes this opportunity in the field of inflammatory bowel disease.”